Pillstats
Rx only · Tablet, Delayed Release · Oral

Mycophenolic Acid

Brands: Myfortic · Mycophenolate Sodium

15 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US37 NDCs
15 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC—
RxCUI (US)—
US makers17 labelers
Packages51
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 28 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$2.07$4.14$6.21$8.28Jan 2025Mar 2026Jul 2026
$0.963
Latest avg · Jul 8, 2026
-87%
Since Jan 14, 2025
15
Active US suppliers
38%
Top-2 supplier share*

Who makes it15 active · 2 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Ascend Laboratories, LLCunknown12SUPPLYING
Major Pharmaceuticalsunknown6SUPPLYING
Biocon Pharma Incunknown4SUPPLYING
Concord Biotech Limitedunknown4SUPPLYING
Accord Healthcare Inc.unknown3SUPPLYING
Slate Run Pharmaceuticals, LLCunknown2SUPPLYING
Novartis Pharmaceuticals Corporationunknown2SUPPLYING
Advagen Pharma Ltdunknown2SUPPLYING
Apotex Corp.unknown2SUPPLYING
Novugen Pharma (USA) LLC.unknown2SUPPLYING
American Health Packagingunknown2SUPPLYING
Aurobindo Pharma Limitedunknown2SUPPLYING
Golden State Medical Supply, Inc.unknown2SUPPLYING
REMEDYREPACK INC.repackager1SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING

+ 2 more labelers

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.